Apellis Pharmaceuticals Inc (APLS)
28.06
-0.19
(-0.67%)
USD |
NASDAQ |
Nov 14, 16:00
27.76
-0.30
(-1.07%)
Pre-Market: 09:28
Apellis Pharmaceuticals Free Cash Flow (Quarterly): 34.10M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 34.10M |
| June 30, 2024 | -8.429M |
| March 31, 2024 | -133.28M |
| December 31, 2023 | -97.97M |
| September 30, 2023 | -169.13M |
| June 30, 2023 | -150.53M |
| March 31, 2023 | -177.88M |
| December 31, 2022 | -141.60M |
| September 30, 2022 | -154.61M |
| June 30, 2022 | -107.42M |
| March 31, 2022 | -111.65M |
| December 31, 2021 | -112.52M |
| September 30, 2021 | -168.98M |
| June 30, 2021 | -128.94M |
| March 31, 2021 | -153.80M |
| December 31, 2020 | 141.27M |
| Date | Value |
|---|---|
| September 30, 2020 | -103.56M |
| June 30, 2020 | -94.83M |
| March 31, 2020 | -108.78M |
| December 31, 2019 | -82.23M |
| September 30, 2019 | -54.07M |
| June 30, 2019 | -40.10M |
| March 31, 2019 | -36.44M |
| December 31, 2018 | -44.48M |
| September 30, 2018 | -33.13M |
| June 30, 2018 | -30.69M |
| March 31, 2018 | -22.94M |
| December 31, 2017 | -15.53M |
| September 30, 2017 | -11.14M |
| June 30, 2017 | -11.50M |
| March 31, 2017 | -8.427M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-177.88M
Minimum
Mar 2023
141.27M
Maximum
Dec 2020
-101.54M
Average
-112.08M
Median
Free Cash Flow (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 200.30M |
| Ionis Pharmaceuticals Inc | -111.30M |
| EyePoint Pharmaceuticals Inc | -40.60M |
| Cassava Sciences Inc | -18.31M |
| Macrogenics Inc | 59.57M |